The Role of P27 in Breast Epithelial Progenitors and Breast Cancer Risk
The Role of P27 in Breast Epithelial Progenitors and Breast Cancer Risk
批准号:
8633710
负责人:
KORNELIA POLYAK
金额:
$20.13万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-02-01 至 2019-01-31
关键词:
AgeAnimal ModelAnimalsAreaBRCA1 geneBiological MarkersBiological ProcessBiologyBreastBreast Cancer PreventionBreast Epithelial CellsBromodeoxyuridineCD44 geneCell Culture TechniquesCell Differentiation processCellsCharacteristicsChemopreventionDataDevelopmentEpidemiologyEpigenetic ProcessEpithelialEpithelial Cell ProliferationEstrogen receptor positiveFatty acid glycerol estersFemaleFibroblastsFormalinFrequenciesGene ExpressionGeneral PopulationGenesGoalsHormonalHormone ResponsiveHumanImmunohistochemistryInfertilityKnockout MiceMME geneMammary Gland ParenchymaMammary NeoplasmsMammary TumorigenesisMammary glandMethodsModelingMolecular ProfilingMouse Mammary Tumor VirusMusMyoepithelialParaffin EmbeddingPathway interactionsPlayPregnancyPreventionPrevention strategyProliferatingPropertyResearchRiskRisk MarkerRoleSamplingSignal PathwaySignal TransductionSliceStratificationTGFB1 geneTestingTimeTissue SampleVariantWomanbasebreast tumorigenesiscancer preventioncancer riskcarcinogenesiscell typehigh riskimprovedin vivoinhibitor/antagonistmalignant breast neoplasmmammary epitheliummutation carrierparityprogenitorself-renewalstemtumor initiationtumorigenesis
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Existing biomarkers and cancer prevention strategies are limited as the biology of breast tumor initiation remains poorly understood. We aim to elucidate mammary epithelial cells that participate in tumorigenesis as a means of developing markers for risk stratification and targets for prevention. Important clues to the identity of these cells come from epidemiologic and our preliminary data. Early full-term pregnancy is one of the most effective protections against breast cancer in most women but not in BRCA1/2 mutation carriers. We investigated parity-associated variation in gene expression profiles of distinct cell types in normal breast tissues of nulliparous and parous women. The most significant differences were seen in CD44+ cells where many genes important in self-renewal and differentiation (e.g., p27, TGFB) were lower in parous women than in nulliparous and in parous BRCA1/2 mutation carriers. The numbers of p27+ and Ki67+ cells were also significantly lower in parous than in nulliparous women except in parous BRCA1/2 cases. The majority of p27+ cells were also estrogen receptor positive. In explant cultures of breast tissues, inhibition of TGFB increased proliferation with a concomitant decrease of p27+ cells implying that p27 due to TGFB is key for keeping breast epithelial progenitors in a quiescent state. Based on these preliminary data, we hypothesize that (1) a subset of p27+ and Ki67+ cells represent quiescent and proliferating hormone-responsive breast epithelial progenitors, respectively, (2) p27 and TGFJ3 play an important role in keeping these progenitors quiescent, (3) the number of these progenitors correlates with breast cancer risk, and (4) mechanisms regulating p27+ progenitors are perturbed in BRCA1/2 mutation carriers and this contributes to their high risk. To test these hypotheses we propose: 1. To characterize the molecular profiles of p27+ and Ki67+ human breast epithelial cells from normal breast tissue of women with different risk of breast cancer. 2. To investigate the role of p27 and signaling pathways that regulates its expression in human breast epithelial cell proliferation and differentiation. 3. To characterize the role of p27 in regulating the abundance of mammary epithelial progenitors and its effect of this on mammary tumorigenesis in animal models.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Epigenetic mechanisms of therapeutic resistance
-
批准号:10627962
-
项目类别:
-
资助金额:$35.88万
-
财政年份:2020
-
负责人:KORNELIA POLYAK
-
依托单位:
Administrative Core - New therapeutic vulnerabilities in breast cancer
-
批准号:10627981
-
项目类别:
-
资助金额:$11.34万
-
财政年份:2020
-
负责人:KORNELIA POLYAK
-
依托单位:
Administrative Core - New therapeutic vulnerabilities in breast cancer
-
批准号:10261469
-
项目类别:
-
资助金额:$11.58万
-
财政年份:2020
-
负责人:KORNELIA POLYAK
-
依托单位:
Epigenetic mechanisms of therapeutic resistance
-
批准号:10434103
-
项目类别:
-
资助金额:$35.88万
-
财政年份:2020
-
负责人:KORNELIA POLYAK
-
依托单位:
New therapeutic vulnerabilities in breast cancer
-
批准号:10434102
-
项目类别:
-
资助金额:$171.86万
-
财政年份:2020
-
负责人:KORNELIA POLYAK
-
依托单位:
Epigenetic mechanisms of therapeutic resistance
-
批准号:10023397
-
项目类别:
-
资助金额:$36.61万
-
财政年份:2020
-
负责人:KORNELIA POLYAK
-
依托单位:
Administrative Core - New therapeutic vulnerabilities in breast cancer
-
批准号:10023400
-
项目类别:
-
资助金额:$12.49万
-
财政年份:2020
-
负责人:KORNELIA POLYAK
-
依托单位:
New therapeutic vulnerabilities in breast cancer
-
批准号:10627961
-
项目类别:
-
资助金额:$171.86万
-
财政年份:2020
-
负责人:KORNELIA POLYAK
-
依托单位:
New therapeutic vulnerabilities in breast cancer
-
批准号:10261465
-
项目类别:
-
资助金额:$175.37万
-
财政年份:2020
-
负责人:KORNELIA POLYAK
-
依托单位:
Epigenetic mechanisms of therapeutic resistance
-
批准号:10261466
-
项目类别:
-
资助金额:$36.61万
-
财政年份:2020
-
负责人:KORNELIA POLYAK
-
依托单位:
New therapeutic vulnerabilities in breast cancer
-
批准号:10023396
-
项目类别:
-
资助金额:$177.3万
-
财政年份:2020
-
负责人:KORNELIA POLYAK
-
依托单位:
Administrative Core - New therapeutic vulnerabilities in breast cancer
-
批准号:10434106
-
项目类别:
-
资助金额:$11.34万
-
财政年份:2020
-
负责人:KORNELIA POLYAK
-
依托单位:
Targeting intratumor heterogeneity in breast cancer
-
批准号:9328033
-
项目类别:
-
资助金额:$54.67万
-
财政年份:2015
-
负责人:KORNELIA POLYAK
-
依托单位:
Targeting intratumor heterogeneity in breast cancer
-
批准号:10208794
-
项目类别:
-
资助金额:$115.71万
-
财政年份:2015
-
负责人:KORNELIA POLYAK
-
依托单位:
Project 3: Single Cell Measures of Intratumor Diversity for Optimal Breast Cancer Therapy
-
批准号:8866714
-
项目类别:
-
资助金额:$39.26万
-
财政年份:2015
-
负责人:KORNELIA POLYAK
-
依托单位:
Targeting intratumor heterogeneity in breast cancer
-
批准号:10705709
-
项目类别:
-
资助金额:$101.55万
-
财政年份:2015
-
负责人:KORNELIA POLYAK
-
依托单位:
Project 4: Combined use of immunotherapy and targeted treatments for triple negative breast cancer
-
批准号:10668347
-
项目类别:
-
资助金额:$30.18万
-
财政年份:2013
-
负责人:KORNELIA POLYAK
-
依托单位:
Core A: Administrative
-
批准号:10668335
-
项目类别:
-
资助金额:$20.15万
-
财政年份:2013
-
负责人:KORNELIA POLYAK
-
依托单位:
Project 4: Combined use of immunotherapy and targeted treatments for triple negative breast cancer
-
批准号:10215416
-
项目类别:
-
资助金额:$33.05万
-
财政年份:2013
-
负责人:KORNELIA POLYAK
-
依托单位:
Project 4: Combined use of immunotherapy and targeted treatments for triple negative breast cancer
-
批准号:10455693
-
项目类别:
-
资助金额:$29.06万
-
财政年份:2013
-
负责人:KORNELIA POLYAK
-
依托单位:
海外基金